DTC advertising to be tightened up
August 4, 2005Medical Communications
New US guidelines for pharmaceutical DTC advertising will come into effect next year as the industry seeks to address public …
Teva’s modest sales growth driven by MS treatment
August 4, 2005Sales and Marketing
Teva Pharmaceuticals, the world's number one generics manufacturer, has posted modest second quarter results driven by its patent-protected multiple sclerosis …
Animal rights attacks curbed by new legislation
August 4, 2005Animal rights activists have dramatically scaled back illegal attacks on medical researchers in the wake of new laws to counteract …
AstraZeneca name McKillop’s successor as sales rise
August 3, 2005Sales and Marketing
Sir Tom McKillop is to step down in January as chief executive of AstraZeneca laying to rest speculation about the …
Survival of the fittest
August 1, 2005Sales and Marketing
The title for this piece was inspired by a sort of scientific hobby I have, which revolves around critical thinking …
Personalising medicine
August 1, 2005Research and Development
Hard times have hit the drug development industry. Faced with declining returns and the apparent waning of blockbusters, coupled with …
Pfizer demands action after counterfeit Lipitor recovered in UK
July 29, 2005Manufacturing and Production
Pfizer has demanded strict new anti-counterfeiting measures in the UK and across Europe following the discovery of fake versions of …
Schering-Plough’s new anti-fungal gains EMEA approval
July 29, 2005Sales and Marketing
A new treatment for fungal infections has been given a positive opinion by the EMEA.Schering-Plough's Noxafil (posaconazole) is a novel …
New drug-resistant HIV treatment recommended
July 28, 2005Sales and Marketing
Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been recommended for approval by the European regulator.The prevalence of …
NICE calls for more Alzheimer’s evidence to head off row
July 20, 2005Manufacturers of three Alzheimer's treatments have been asked to supply more information to NICE to help decide whether or not …
PR group launched to counter pharma’s poor public image
July 20, 2005Medical Communications
A new forum has been launched to promote dialogue between healthcare stakeholders and improve public perception of the pharma industry.The …
New 28-day pack for Cozaar launched
July 20, 2005Sales and Marketing
A new 28-day pack of Merck Sharp & Dohme's top-selling hypertension treatment Cozaar has been launched in the UK.The 50mg …
Arixtra approved for new blood clot indication
July 20, 2005Sales and Marketing Arixtra, GlaxoSmithKline
GlaxoSmithKline’s Arixtra has gained approval for use in preventing blood clots in high-risk patients undergoing abdominal surgery.The drug is already …
Iressa successor enters phase III
July 19, 2005Research and Development, Sales and Marketing
AstraZeneca's oncology compound ZD6474 has entered phase III trials after positive results in trials in non-small cell lung cancer.The drug, …
AstraZeneca invests in novel cholesterol drugs
July 15, 2005Research and Development
AstraZeneca is investing in a range of next generation cholesterol drugs which could reverse existing vascular disease in patients.The Anglo-Swedish …
Latest content
